Latest news and press releases about Outset Medical, Inc. (OM): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features.
Price
| Price | $3.10 |
| Market Cap | $57M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.59 |
| EV / EBITDA | -2.42 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -62.25% |
| Return on Invested Capital | -32.84% |
| Return on Assets | -30.65% |
| Gross Margin | 41.76% |
| Operating Margin | -56.06% |
| Net Margin | -63.06% |
Related companies: CATX · HSDT · INGN · NNOX · OMI · QTRX · SI
Explore sector: Healthcare · Medical - Devices
More sections of OM: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks